Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass
Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin and observe any association with increased risk of excessive coagulation activation, morbidity, or mortality.
Design: Prospective, observational cohort study.
Setting: University hospital.
Participants: Patients (n = 96) undergoing cardiopulmonary bypass for various types of surgery.
Interventions: None.
Measurements and Main Results: TFPI antigen and activity were determined in patients before and after heparin administration, before cardiopulmonary bypass for cardiac surgery. The clinical progress of each patient was recorded. Median levels of TFPI activity were 0.98 U/mL (interquartile range, 0.83 to 1.14 U/mL) preheparin and 2.34 U/mL (2.18 to 2.54 U/mL) postheparin (p [lt ] 0.0001), representing a median 2.3-(2.1- to 2.8-) fold increase. Median TFPI antigen levels were 92.4 ng/mL (73.0 to 119.5 ng/mL) preheparin and 422.9 ng/mL (398.7 to 501.6 ng/mL) postheparin (p [lt ] 0.0001), representing a median 4.6-fold (3.6- to 6.2-fold) increase. Two patients had low ([lt ]300 ng/mL) postheparin levels of TFPI antigen that were not associated with low functional TFPI or adverse clinical outcome. Fourteen patients showed a low ratio of increased functional TFPI postheparin; all had a ratio of TFPI antigen increase of at least 3-fold.
Conclusion: The TFPI response to heparin is heterogenous. Two nonresponders were identified, with low postheparin levels of TFPI antigen, who did not suffer adverse clinical outcomes.
59-63
Adams, Murray J.
998392cc-7607-440d-a623-7cd8623d7b33
Cardigan, Rebecca A.
3689bea8-2369-4e7b-82b4-07dad2553cd6
Marchant, Warwick A.
163bc660-6a50-46e5-a0e8-e6881efdde2d
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Mythen, Monty G.
266ffcca-f8dd-49b4-abe4-0ffb035e2b35
Mutch, Maj
11f09753-641d-4698-a2fe-2c508ca75039
Purdy, Gordon
ff6abfa1-b88d-4f78-aedb-45c29ab7127e
Mackie, Ian J.
c5691ce5-831b-4270-a0d7-e03e2f6a6cd3
Machin, Samuel J.
9245248c-86ae-4059-a5a1-7b21a8ead316
February 2002
Adams, Murray J.
998392cc-7607-440d-a623-7cd8623d7b33
Cardigan, Rebecca A.
3689bea8-2369-4e7b-82b4-07dad2553cd6
Marchant, Warwick A.
163bc660-6a50-46e5-a0e8-e6881efdde2d
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Mythen, Monty G.
266ffcca-f8dd-49b4-abe4-0ffb035e2b35
Mutch, Maj
11f09753-641d-4698-a2fe-2c508ca75039
Purdy, Gordon
ff6abfa1-b88d-4f78-aedb-45c29ab7127e
Mackie, Ian J.
c5691ce5-831b-4270-a0d7-e03e2f6a6cd3
Machin, Samuel J.
9245248c-86ae-4059-a5a1-7b21a8ead316
Adams, Murray J., Cardigan, Rebecca A., Marchant, Warwick A., Grocott, Michael P.W., Mythen, Monty G., Mutch, Maj, Purdy, Gordon, Mackie, Ian J. and Machin, Samuel J.
(2002)
Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass.
Journal of Cardiothoracic and Vascular Anesthesia, 16 (1), .
(doi:10.1053/jcan.2002.29677).
(PMID:11854880)
Abstract
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin and observe any association with increased risk of excessive coagulation activation, morbidity, or mortality.
Design: Prospective, observational cohort study.
Setting: University hospital.
Participants: Patients (n = 96) undergoing cardiopulmonary bypass for various types of surgery.
Interventions: None.
Measurements and Main Results: TFPI antigen and activity were determined in patients before and after heparin administration, before cardiopulmonary bypass for cardiac surgery. The clinical progress of each patient was recorded. Median levels of TFPI activity were 0.98 U/mL (interquartile range, 0.83 to 1.14 U/mL) preheparin and 2.34 U/mL (2.18 to 2.54 U/mL) postheparin (p [lt ] 0.0001), representing a median 2.3-(2.1- to 2.8-) fold increase. Median TFPI antigen levels were 92.4 ng/mL (73.0 to 119.5 ng/mL) preheparin and 422.9 ng/mL (398.7 to 501.6 ng/mL) postheparin (p [lt ] 0.0001), representing a median 4.6-fold (3.6- to 6.2-fold) increase. Two patients had low ([lt ]300 ng/mL) postheparin levels of TFPI antigen that were not associated with low functional TFPI or adverse clinical outcome. Fourteen patients showed a low ratio of increased functional TFPI postheparin; all had a ratio of TFPI antigen increase of at least 3-fold.
Conclusion: The TFPI response to heparin is heterogenous. Two nonresponders were identified, with low postheparin levels of TFPI antigen, who did not suffer adverse clinical outcomes.
This record has no associated files available for download.
More information
Published date: February 2002
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 348973
URI: http://eprints.soton.ac.uk/id/eprint/348973
ISSN: 1053-0770
PURE UUID: 78c5dab3-c92f-4cc0-b7ce-a1077e3b0123
Catalogue record
Date deposited: 27 Feb 2013 11:28
Last modified: 15 Mar 2024 03:33
Export record
Altmetrics
Contributors
Author:
Murray J. Adams
Author:
Rebecca A. Cardigan
Author:
Warwick A. Marchant
Author:
Monty G. Mythen
Author:
Maj Mutch
Author:
Gordon Purdy
Author:
Ian J. Mackie
Author:
Samuel J. Machin
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics